Do arterial effects of antihypertensive drugs depend on subject's serum cholesterol?

J L Megnien1, A Simon, E Mikaberidze

  • 1Centre of Preventive Cardiovascular Medicine and CRI INSERM, Hôpital Broussais, Paris, France.

Insights

Antihypertensive drugs nitrendipine and trandolapril affect large arteries differently, with nitrendipine

Area of Science:

  • Cardiovascular Pharmacology
  • Arterial Biomechanics

Background:

  • Antihypertensive treatment effects on large arteries can be influenced by drug class and cholesterol levels.
  • Essential hypertension impacts arterial properties, necessitating investigation into drug-specific vascular effects.

Purpose of the Study:

  • To compare the effects of nitrendipine and trandolapril on carotid artery parameters in hypertensive patients with varying cholesterol levels.
  • To determine if blood cholesterol status modulates the vascular response to these antihypertensive agents.

Main Methods:

  • Investigated 39 hypertensive patients (20 low cholesterol, 19 high cholesterol) randomly assigned to 3 months of nitrendipine or trandolapril.
  • Assessed carotid artery parameters including pressure, diameter, Peterson modulus, stiffness index, compliances, and wall viscosity using applanation tonometry and echotracking.
  • Modeled pressure-diameter loops to derive biomechanical properties.

Main Results:

  • Nitrendipine and trandolapril showed differential effects on carotid systolic and diastolic diameters.
  • Trandolapril decreased diameters (p < 0.01), while nitrendipine caused insignificant increases.
  • Nitrendipine's effects on pressures, diastolic diameter, and wall viscosity varied significantly between low and high cholesterol groups (p < 0.05).
  • Wall viscosity changes under nitrendipine correlated positively with baseline cholesterol (r = 0.64, p < 0.01).

Conclusions:

  • Nitrendipine and trandolapril exhibit distinct effects on carotid artery biomechanics in hypertensive patients.
  • Blood cholesterol status significantly influences nitrendipine's vascular effects, but not trandolapril's.
  • Further larger studies are warranted to confirm these cholesterol-dependent differences in antihypertensive drug action.

Related Concept Videos

Lipid-Lowering Drugs: Statins and Miscellaneous Agents01:20

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
Chronopharmacokinetics: Circadian Rhythms and Influence on Drug Response01:15

Chronopharmacokinetics: Circadian Rhythms and Influence on Drug Response

Circadian rhythms are cyclic changes that are crucial in plasma drug concentrations. Various standard circadian parameters, including core body temperature, heart rate, and other cardiovascular factors, directly impact disease states and the therapeutic response to drug therapy.
The time of drug administration is an important factor to consider, as it can influence the toxic dose of a drug. For example, a study conducted by Prins et al. in 1997 examined the effects of the timing of...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Antihypertensive Drugs: Angiotensin II Receptor Blockers01:30

Antihypertensive Drugs: Angiotensin II Receptor Blockers

In the renin-angiotensin-aldosterone system, a hormone called angiotensin II plays a crucial role. It binds to the AT1 receptors in vascular smooth muscles coupled with Gq proteins. The activation of these receptors activates an enzyme called phospholipase C, which releases two molecules: inositol trisphosphate and diacylglycerol. These molecules cause a chain reaction that leads to the phosphorylation of myosin light chains and promotes interaction between actin and myosin, leading to smooth...
Antihypertensive Drugs: Vasodilators01:23

Antihypertensive Drugs: Vasodilators

Vasodilators, primarily affecting the smooth muscles within arterial and venous walls, are commonly used for hypertension treatment. Medications such as minoxidil and hydralazine primarily target arteries and arterioles, while sodium nitroprusside acts on arterioles and venules. Minoxidil, functioning as a prodrug, is metabolized by hepatic sulfotransferase into its active form, minoxidil sulfate, after oral administration. This metabolite binds to the sulfonylurea receptor (SUR) component of...
Antihypertensive Drugs: Direct Renin Inhibitors01:25

Antihypertensive Drugs: Direct Renin Inhibitors

The renin-angiotensin-aldosterone system (RAAS) is an intricate physiological pathway involving numerous enzymes and hormones, including renin, angiotensin-converting enzyme (ACE), angiotensin I and II, and aldosterone. Imbalances within this system increase the production of angiotensin II and aldosterone. Increased angiotensin II levels promote vasoconstriction and blood pressure elevation. Concurrently, higher aldosterone levels stimulate sodium and water reabsorption in the kidneys,...